SCHEMBL82033

SCHEMBL82033

CC1(C)c2ccccc2-c2nc(-c3ccc4ncc(-c5ccc6c(n5)-c5ccccc5C6(C)C)cc4c3)ccc21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 5/20 0.36
PDGFRA P16234 4/20 0.36
LCK P06239 1/20 0.35
KDR P35968 1/20 0.35
JAK3 P52333 1/20 0.35
MAPK14 Q16539 1/20 0.35
NR2F2 P24468 1/20 0.35
PIK3CA P42336 4/20 0.35
PIK3CD O00329 3/20 0.35
MTOR P42345 3/20 0.33
TGFBR1 P36897 1/20 0.33
TDP2 O95551 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
TRPV3 Q8NET8 1/20 0.33
PDK2 Q15119 1/20 0.33
NPC1 O15118 1/20 0.33
MAP4K4 O95819 1/20 0.32
CSNK1G2 P78368 1/20 0.32
CLK4 Q9HAZ1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL82016 0.91 PDGFRB (0.41) PDGFRBPDGFRANR2F2PIK3CAPIK3CD
SCHEMBL80795 0.86 KDM4E (0.35) PDGFRBPDGFRAPDK2KMT2A
SCHEMBL80785 0.86 PDK2 (0.34) PDGFRBPDGFRAPDK2KMT2A
SCHEMBL81183 0.85 PDK2 (0.38) PDK2KMT2A
SCHEMBL81955 0.85 MAOB (0.38) PDGFRBNPC1KMT2A
SCHEMBL80251 0.84 MAOB (0.38) PDGFRBNPC1KMT2A
SCHEMBL80301 0.84 KMT2A (0.34) PDK2NPC1KMT2A
SCHEMBL81536 0.83 MAOB (0.37) PDGFRBNPC1KMT2A
SCHEMBL81002 0.83 PDK2 (0.33) PDK2NPC1KMT2A
SCHEMBL82098 0.83 RARB (0.35) PIK3CDPDK2NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129899-B1 Azafluorene derivative and organic light-emitting device using the derivative CANON KABUSHIKI KAISHA (JP) 2012-03-06 US disclosed
US-8129899-B1 Azafluorene derivative and organic light-emitting device using the derivative CANON KABUSHIKI KAISHA (JP) 2012-03-06 US disclosed
US-20120049176-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2012-03-01 US disclosed
US-20120049176-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2012-03-01 US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-8110685-B2 Efficient, durable electron transport layers; low driving voltage; simple, low cost production CANON KABUSHIKI KAISHA (JP) 2012-02-07 US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 US disclosed
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE CANON KABUSHIKI KAISHA (JP) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080154040-A1 AZAFLUORENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE USING THE DERIVATIVE AZI2, CYP1A2, CYP2C19 PDGFRB 4126/4885PDGFRA 3312/4885LCK 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.